A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjects
Clinical trial NCT02460393 · COMPLETED
Trial details
- NCT number
- NCT02460393
- Sponsor
- Shenyang Sunshine Pharmaceutical Co., LTD.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2015-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.